Scientific research has again shed some light on the fight against colon cancer, one of the most common tumors in Spain and the leading cause of cancer death when men and women are added. Researchers at the Hospital del Mar in Barcelona have identified a new drug (the Sym004) against a type of metastatic cancer that had no further therapeutic course when conventional drugs failed.

Scientists have shown that the new drug improves the quality and life expectancy of patients with metastatic colon tumors who have a mutation in the EGFR gene (this metamorphosis of the gene is what causes the malignancy to be resistant to the usual treatments ). More information.